Want to join the ABTA virtual 50 mile Facebook Challenge? Check it out here.
Join this webinar to learn about the role of IDH inhibitors in brain tumor care and explore the latest advancements in IDH-targeted therapies, including the newly FDA-approved treatment, vorasidenib.
In this Webinar, you will:
Presenter: John de Groot, MD
Dr. John de Groot is a neuro-oncologist who specializes in diagnosing and managing the care of patients with primary brain and spine tumors.
This webinar will have Spanish subtitles available.
Este seminario de web tendrá subtítulos en español.
The need for better brain tumor treatments is greater than ever. That’s why we’re meeting hope head on—because donations lead to research, research leads to better treatments, and better treatments bring us closer to a cure.
The ABTA has been a top resource for brain tumor educational materials for over 50 years. All of our educational brochures are carefully reviewed by brain tumor medical experts, and brain tumor patients and caregivers.. These brochures are 100% free for patients and caregivers.
Donating to the ABTA is a meaningful way to recognize someone whose life has been impacted by a brain tumor. With your gift, you can honor key milestones in a brain tumor survivor’s life, or convey the sense of loss when a friend or loved one loses their battle with this disease.